Introduction
Transient ischemic dilation (TID) of the left ventricle—a ratio of the stress left ventricular (LV) volume to rest LV volume—on myocardial perfusion imaging has been described as a useful marker of severe and extensive coronary artery disease (CAD).1 , 2 TID measurement has also been shown to have distinct prognostic value,3 with abnormal TID indicating increased risk of myocardial infarction or cardiac death.4 TID is currently used in clinical practice and is routinely reported by most major quantitative software packages. The mechanisms of this relative increase of measured left ventricular volume at stress have been considered to be an apparent cavity size at stress due to subendocardial ischemia, a true increase in left ventricular volume persisting at the time of post-stress imaging due to stress-induced LV stunning, or a combination of both.5 , 6
In this issue of Journal of Nuclear Cardiology®, Jameria et al.7 study in detail the TID derivation for the scans obtained with a new Cadmium Zinc Telluride (CZT) camera in the upright position. The TID measurements have not been studied yet on these new cameras. Potentially due to an increased resolution and different imaging position, the normal TID values could differ on these new systems. In regards to image resolution, it has been suggested that TID may be unreliable in small hearts, if reconstructed image resolution is too low2. So how do the results presented by Jameria et al. compare to recent studies of TID? Table 1 lists several recent published reports with various 99mTc protocols, stress methods, software tools, criterions for cut-off, and definitions of normal population. Other studies have been published previously for dual-isotope protocols.8 , 9 In Table 1, it can be seen that normal cut-off values obtained by Jameria et al. are in fact remarkably similar to the values reported for exercise or pharmacological stress obtained with conventional imaging systems, including one previous report of TID in patients imaged in upright position.10 Similar to previous reports, the threshold defined as 2 standard deviations (SD) above the mean is indeed higher for the pharmacological stress studies than for the exercise studies. When comparing these recent reports, one can appreciate that there are several potential factors affecting the value of the normal threshold, such as imaging protocol, patient position, normal population definition, statistical threshold definition, and software used for TID computation. Nevertheless, despite these methodological differences, the abnormal TID cut-offs seem to be consistent across these reports.
Some technical factors should be pointed out with regards to the study by Jameria et al. Does upright position affect the results? It is hard to tell since there are no paired supine TID measurements obtained in this report. In some clinical protocols, the upright and supine images are obtained both at stress and rest and therefore such comparison could be feasible in future studies. The normal TID cut-off values do not seem to differ from these reported by other studies despite the use of CZT camera. The number of normal regadenoson cases used for the derivation of normal limits is rather low, reflecting practical difficulty, since patients with low likelihood of disease are unlikely to undergo pharmacological stress. The authors Jameria et al. utilize the average of upright and supine perfusion results for the definition of the perfusion defect used in their analyses, which is not a typical method in two-position protocols. In this regard, it has been shown previously that the defect must be present in both supine and upright images for more optimal diagnosis.11 No attenuation correction was used, however, attenuation correction was not used in any of the studies of TID presented in Table 1. This fact should be kept in mind when using TID clinically.
How to use TID Clinically?
The several studies of the clinical utility of TID presented in Table 1 attempt to define the normal limits in order to then use this binary variable to help in detecting extensive/severe CAD or indicate increased risk for adverse outcomes. However, TID is not used as a solitary variable to identify extensive/severe CAD or adverse prognosis. Regarding detecting extensive/severe CAD, TID on its own has low sensitivity; however, using the combination of the presence or absence of TID and assessment of the presence and size of myocardial perfusion defect, it is possible to increase the overall sensitivity for the detection of severe disease with unchanged specificity.12 This combination can be accomplished for example by developing specialized rules combining total perfusion deficit (TPD) and TID variables as demonstrated by Xu et al.12
While TID has been studied as a binary variable (present or absent), one may question whether a TID of 1.5 has the same prognostic information as TID of 1.17 (just barely above the arbitrary 2SD threshold) for a given patient. Indeed, reported lack of added value of TID for detection of severe disease with pharmacologic testing13 could be related to the analytic deficiency of using only an arbitrary binary cut-off for TID. It is likely that a continuous variable of TID may provide a better predictor of severe/extensive CAD or patient risk. Continuous TID variable could be matched with the individual patient profile and contribute to the individual risk estimate. Thus, TID variable should not be thought of as a standalone marker with its own normal limits, but rather as a continuous measure which is optimally combined with multiple other variables. But how might such a continuous TID variable be optimally utilized in clinical practice?
The most effective method would be perhaps to create a machine learning model where a continuous TID variable is incorporated with all other key variables such as perfusion deficit, ejection fraction, clinical data, and even an imaging protocol (dual/single isotope, stress type) in the overall diagnosis or risk assessment. In such approach, there would be no need to define an arbitrary abnormal TID threshold and a continuous final probability of disease or outcome can be computed. This final computed probability can be then discretized to several categories of risk or probability of disease, rather than just assigning a normal/abnormal finding. Indeed, such holistic approach has been shown to be very promising in diagnostic14 and prognostic15 , 16 applications demonstrating a significant overall improvement of diagnostic accuracy or risk reclassification.
Summary
Multiple publications have reported the normal limits of TID measurements with 99mTc SPECT MPI including exercise and pharmacological stress as well as their diagnostic and prognostic utilities. In general, the reported TID abnormal thresholds have been shown to be lower in studies with exercise stress than in studies with pharmacological stress, but otherwise the normal values of TID were similar. In all of these reports, an arbitrary cut-off value for abnormal TID was used for either diagnostic or prognostic purposes. However, TID should be used in combination with other imaging and clinical variables. Continuous TID measure could be utilized efficiently by machine learning models, allowing more precise overall risk or diagnostic stratification, and obviating the need for arbitrary TID cut-offs.
References
Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.
Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612-20.
McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600-5.
Lester D, El-Hajj S, Farag AA, Bhambhvani P, Tauxe L, Heo J, et al. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging. J Nucl Cardiol 2015. doi:10.1007/s12350-015-0272-7.
Abidov A, Berman DS. Transient ischemic dilation associated with poststress myocardial stunning of the left ventricle in vasodilator stress myocardial perfusion SPECT: True marker of severe ischemia? J Nucl Cardiol 2005;12:258-60.
Marcassa C, Galli M, Baroffio C, Campini R, Giannuzzi P. Transient left ventricular dilation at quantitative stress-rest sestamibi tomography: Clinical, electrocardiographic, and angiographic correlates. J Nucl Cardiol 1999;6:397-405.
Jameria ZA, Abdallah M, Dwivedi A, Washburn E, Khan N, Khaleghi M, et al. Computer derived transient ischemic dilation ratio for identifying extensive coronary artery disease using a CZT camera and imaging in upright position. J Nucl Cardiol 2016. doi:10.1007/s12350-016-0515-2.
Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45:1999-2007.
Katz JS, Ruisi M, Giedd KN, Rachko M. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing. J Nucl Cardiol 2012;19:727-34.
Doukky R, Frogge N, Bayissa YA, Balakrishnan G, Skelton JM, Confer K, et al. The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: A cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol 2013;20:774-84.
Nakazato R, Tamarappoo BK, Kang X, Wolak A, Kite F, Hayes SW, et al. Quantitative upright-supine high-speed SPECT myocardial perfusion imaging for detection of coronary artery disease: Correlation with invasive coronary angiography. J Nucl Med 2010;51:1724-31.
Xu Y, Arsanjani R, Clond M, Hyun M, Lemley M Jr, Fish M, et al. Transient ischemic dilation for coronary artery disease in quantitative analysis of same-day sestamibi myocardial perfusion SPECT. J Nucl Cardiol 2012;19:465-73.
Golzar Y, Olusanya A, Pe N, Dua SG, Golzar J, Gidea C, et al. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol 2015;22:526-34.
Arsanjani R, Xu Y, Dey D, Vahistha V, Shalev A, Nakanishi R, et al. Improved accuracy of myocardial perfusion SPECT for detection of coronary artery disease by machine learning in a large population. J Nucl Cardiol 2013;20:553-62.
Arsanjani R, Dey D, Khachatryan T, Shalev A, Hayes SW, Fish M, et al. Prediction of revascularization after myocardial perfusion SPECT by machine learning in a large population. J Nucl Cardiol 2015;22:877-84.
Motwani M, Dey D, Berman DS, Germano G, Achenbach S, Al-Mallah MH, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: A 5-year multicentre prospective registry analysis. Eur Heart J 2016
Mandour Ali MA. Bourque JM, Allam AH, Beller GA and Watson DD. The prevalence and predictive accuracy of quantitatively defined transient ischemic dilation of the left ventricle on otherwise normal SPECT myocardial perfusion imaging studies. J Nucl Cardiol 2011;18:1036-43.
Acknowledgments
This research was supported in part by Grant R01HL089765 from the National Heart, Lung, and Blood Institute/National Institute of Health (NHLBI/NIH) (PI: PS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NHLBI/NIH.
Disclosure
Cedars-Sinai Medical Center receives royalties for the quantitative assessment of function, perfusion, and viability, a minority portion of which is distributed to some of the authors of this manuscript (Guido Germano and Piotr J. Slomka).
Author information
Authors and Affiliations
Corresponding author
Additional information
See related article, doi:10.1007/s12350-016-0515-2.
Rights and permissions
About this article
Cite this article
Slomka, P.J., Berman, D.S. & Germano, G. Normal limits for transient ischemic dilation with 99mTc myocardial perfusion SPECT protocols. J. Nucl. Cardiol. 24, 1709–1711 (2017). https://doi.org/10.1007/s12350-016-0582-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-016-0582-4